Cargando…

Prognostic factors for the severity of SARS-CoV-2 infection

OBJECTIVES: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a novel coronavirus that causes COVID-19. This disease is associated with leukocytosis with lymphopenia, neutrophilia, and elevated levels of d-dimer, and C-reactive protein, ferritin, procalcitonin, and lactate dehydrogenase....

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio-Sánchez, Ricardo, Lepe-Balsalobre, Esperanza, Viloria-Peñas, María del Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197509/
https://www.ncbi.nlm.nih.gov/pubmed/37363332
http://dx.doi.org/10.1515/almed-2021-0017
_version_ 1785044567330914304
author Rubio-Sánchez, Ricardo
Lepe-Balsalobre, Esperanza
Viloria-Peñas, María del Mar
author_facet Rubio-Sánchez, Ricardo
Lepe-Balsalobre, Esperanza
Viloria-Peñas, María del Mar
author_sort Rubio-Sánchez, Ricardo
collection PubMed
description OBJECTIVES: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a novel coronavirus that causes COVID-19. This disease is associated with leukocytosis with lymphopenia, neutrophilia, and elevated levels of d-dimer, and C-reactive protein, ferritin, procalcitonin, and lactate dehydrogenase. The aim of this study was to describe the clinical and analytical characteristics of hospitalized patients with SARS-CoV-2 infection and to identify prognostic factors of disease progression. METHODS: Patients were categorized into two groups based on COVID-19 severity. Study variables included demographic data, medical history, length of hospital stay, course of pneumonia, drug therapy, and analytical parameters. A descriptive and multivariate analysis was performed to identify prognostic factors for disease severity. RESULTS: The study population included 197 patients, of whom 127 had mild disease and 70 had severe COVID-19. Statistically significant differences were observed in most analytical parameters. The parameters included in the multivariate analysis were advanced age and elevated levels of leukocytes, CRP, GGT, and PCT at admission as prognostic factors for disease severity. CONCLUSIONS: The prognostic factors for the severity of SARS-CoV-2 infection identified in this study (age, leukocytes, CRP, GGT, and PCT) will help predict the course of the disease at an early stage.
format Online
Article
Text
id pubmed-10197509
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-101975092023-06-23 Prognostic factors for the severity of SARS-CoV-2 infection Rubio-Sánchez, Ricardo Lepe-Balsalobre, Esperanza Viloria-Peñas, María del Mar Adv Lab Med Article OBJECTIVES: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a novel coronavirus that causes COVID-19. This disease is associated with leukocytosis with lymphopenia, neutrophilia, and elevated levels of d-dimer, and C-reactive protein, ferritin, procalcitonin, and lactate dehydrogenase. The aim of this study was to describe the clinical and analytical characteristics of hospitalized patients with SARS-CoV-2 infection and to identify prognostic factors of disease progression. METHODS: Patients were categorized into two groups based on COVID-19 severity. Study variables included demographic data, medical history, length of hospital stay, course of pneumonia, drug therapy, and analytical parameters. A descriptive and multivariate analysis was performed to identify prognostic factors for disease severity. RESULTS: The study population included 197 patients, of whom 127 had mild disease and 70 had severe COVID-19. Statistically significant differences were observed in most analytical parameters. The parameters included in the multivariate analysis were advanced age and elevated levels of leukocytes, CRP, GGT, and PCT at admission as prognostic factors for disease severity. CONCLUSIONS: The prognostic factors for the severity of SARS-CoV-2 infection identified in this study (age, leukocytes, CRP, GGT, and PCT) will help predict the course of the disease at an early stage. De Gruyter 2021-03-03 /pmc/articles/PMC10197509/ /pubmed/37363332 http://dx.doi.org/10.1515/almed-2021-0017 Text en © 2021 Ricardo Rubio-Sánchez et al., published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Article
Rubio-Sánchez, Ricardo
Lepe-Balsalobre, Esperanza
Viloria-Peñas, María del Mar
Prognostic factors for the severity of SARS-CoV-2 infection
title Prognostic factors for the severity of SARS-CoV-2 infection
title_full Prognostic factors for the severity of SARS-CoV-2 infection
title_fullStr Prognostic factors for the severity of SARS-CoV-2 infection
title_full_unstemmed Prognostic factors for the severity of SARS-CoV-2 infection
title_short Prognostic factors for the severity of SARS-CoV-2 infection
title_sort prognostic factors for the severity of sars-cov-2 infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197509/
https://www.ncbi.nlm.nih.gov/pubmed/37363332
http://dx.doi.org/10.1515/almed-2021-0017
work_keys_str_mv AT rubiosanchezricardo prognosticfactorsfortheseverityofsarscov2infection
AT lepebalsalobreesperanza prognosticfactorsfortheseverityofsarscov2infection
AT viloriapenasmariadelmar prognosticfactorsfortheseverityofsarscov2infection